Skip to main content

MariMed Inc.

corporate_fare Company Profile

MariMed Inc.

MRMD·OTC·Life Sciences·CIK 0001522767

We are a multi-state cannabis operator (MSO) in the United States, headquartered in Norwood, Massachusetts. We develop, own, and manage state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis, operating on a seed-to-sale model. We create and develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products using our proprietary strains and formulations. We also license our proprietary brands in select domestic markets, though these revenues are not material to our overall results. Our operations comply with applicable state and local laws and regulations in the jurisdictions where we operate, as cannabis remains illegal under United States federal law. We entered the cannabis industry as an advisory and real estate management firm, procuring state-issued cannabis licenses for clients, developing facilities leased to them, and providing expertise. In 2018, we transitioned to a direct owner and operator of cannabis licenses, primarily in Eastern and Midwestern states. This involved acquiring and consolidating clients for whom we had secured licenses, developed facilities, funded operations, and provided guidance. By early 2025, we had substantially completed these acquisitions and integrations. Our operations expanded through additional M&A activity, making us one of the larger MSOs in the U.S. based on reported annual revenue. We have consistently created our own brands of craft-quality cannabis flower, concentrates, edibles, and other precision-dosed products.

MariMed Inc. (OTC:MRMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for MRMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for MRMD spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • MariMed 10-Q: Record $44.2M Q3 Revenue, But Net Loss Widens to $3.5M
  • MariMed Q3 Revenue Hits $44.2M, Adjusted EBITDA $4.7M as Net Loss Widens
  • MariMed Holders Approve 1-for-50 to 1-for-100 Reverse Split; Board Undecided on Timing
  • MariMed Sets October 28 Vote on 1-for-50 to 1-for-100 Reverse Split to Enable Uplisting
  • MariMed Seeks Shareholder Approval for 1-for-50 to 1-for-100 Reverse Stock Split to Enable Uplisting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$159.83M
Net Income
-$14.48M
Diluted EPS
-$0.04
Op. Cash Flow
$7.7M
Free Cash Flow
$6.53M
Gross Profit
$57.88M
Operating Income
-$2.82M
Cash & Equivalents
$8.88M
Total Debt
$76.04M
Debt / Equity
1.52×
Net Margin
-9.1%
Shares Outstanding
396.91M sh
Source: 10-K · filed 2026-03-12 · accession 0001522767-26-000030

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 18,486 shares in MRMD as of the October 30, 2026 settlement, a 1748.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 74.3% of MRMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)18,486 shares as of October 30, 2026
Change vs prior period▲ 1748.6%
Days to cover1.00 at avg daily volume of 761,607
Daily short volume (FINRA facilities)74.3% of 524,713 shares on November 19, 2026
5-day average short volume35.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$0.0474 -3.18% today
52-week range · as of 2026-11-12 $0.045 – $0.1595
Market cap
$19.26M
Volume
499K (0.6× avg)
3-mo avg 859.8K
Live data · 2026-11-20 20:44 UTC · Market open

show_chartPrice Chart

Loading chart...

feed MRMD - Latest Insights

MRMD
Nov 12, 2026, 5:43 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.075
Real-time Price: $0.04744 info
Change: -$0.02756 (-37%) info
Market Cap: $19.26M info
MRMD
Nov 11, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.0745
Real-time Price: $0.04744 info
Change: -$0.02706 (-36%) info
Market Cap: $19.26M info
MRMD
Oct 29, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.053
Real-time Price: $0.04744 info
Change: -$0.00556 (-10%) info
Market Cap: $19.26M info
MRMD
Sep 22, 2026, 4:42 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.0732
Real-time Price: $0.04744 info
Change: -$0.02576 (-35%) info
Market Cap: $19.26M info
MRMD
Sep 11, 2026, 4:06 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.0788
Real-time Price: $0.04744 info
Change: -$0.03136 (-40%) info
Market Cap: $19.26M info
MRMD
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.065
Real-time Price: $0.04744 info
Change: -$0.01756 (-27%) info
Market Cap: $19.26M info
MRMD
Aug 12, 2026, 5:11 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.06405
Real-time Price: $0.04744 info
Change: -$0.01661 (-26%) info
Market Cap: $19.26M info
MRMD
May 14, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0815
Real-time Price: $0.04744 info
Change: -$0.03406 (-42%) info
Market Cap: $19.26M info
MRMD
May 13, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.084
Real-time Price: $0.04744 info
Change: -$0.03656 (-44%) info
Market Cap: $19.26M info
MRMD
May 13, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.084
Real-time Price: $0.04744 info
Change: -$0.03656 (-44%) info
Market Cap: $19.26M info
MRMD
Apr 23, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.079
Real-time Price: $0.04744 info
Change: -$0.03156 (-40%) info
Market Cap: $19.26M info
MRMD
Mar 12, 2026, 4:08 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.07714
Real-time Price: $0.04744 info
Change: -$0.0297 (-39%) info
Market Cap: $19.26M info
MRMD
Mar 11, 2026, 5:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.07945
Real-time Price: $0.04744 info
Change: -$0.03201 (-40%) info
Market Cap: $19.26M info
MRMD
Mar 02, 2026, 4:15 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.081
Real-time Price: $0.04744 info
Change: -$0.03356 (-41%) info
Market Cap: $19.26M info
MRMD
Mar 02, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.081
Real-time Price: $0.04744 info
Change: -$0.03356 (-41%) info
Market Cap: $19.26M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets